Skip to main content
Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
315.69
+0.79 (0.25%)
Oct 24, 2024, 4:00 PM EDT - Market closed

Amgen Revenue

Amgen had revenue of $8.39B in the quarter ending June 30, 2024, with 20.07% growth. This brings the company's revenue in the last twelve months to $30.93B, up 16.37% year-over-year. In the year 2023, Amgen had annual revenue of $28.19B with 7.09% growth.

Revenue (ttm)
$30.93B
Revenue Growth
+16.37%
P/S Ratio
5.46
Revenue / Employee
$1,158,577
Employees
26,700
Market Cap
169.63B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202328.19B1.87B7.09%
Dec 31, 202226.32B344.00M1.32%
Dec 31, 202125.98B555.00M2.18%
Dec 31, 202025.42B2.06B8.83%
Dec 31, 201923.36B-385.00M-1.62%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pfizer 55.17B
Sanofi 50.44B
Novartis AG 48.86B
Thermo Fisher 42.35B
Abbott Laboratories 41.22B
Danaher 22.49B
Stryker 21.39B
Boston Scientific 15.23B
Revenue Rankings

AMGN News

More News